ATE531726T1 - Verfahren zum nachweis der expression eines hüllproteins eines endogenen menschlichen retrovirus und verwendungen des gens, das für solch ein protein kodiert - Google Patents

Verfahren zum nachweis der expression eines hüllproteins eines endogenen menschlichen retrovirus und verwendungen des gens, das für solch ein protein kodiert

Info

Publication number
ATE531726T1
ATE531726T1 AT00960783T AT00960783T ATE531726T1 AT E531726 T1 ATE531726 T1 AT E531726T1 AT 00960783 T AT00960783 T AT 00960783T AT 00960783 T AT00960783 T AT 00960783T AT E531726 T1 ATE531726 T1 AT E531726T1
Authority
AT
Austria
Prior art keywords
vector
therapeutic
composition containing
protein
gene
Prior art date
Application number
AT00960783T
Other languages
German (de)
English (en)
Inventor
Francois Mallet
Francois-Loic Cosset
Jean-Luc Blond
Dimitri Lavillette
Olivier Bouton
Alessia Ruggieri
Original Assignee
Bio Merieux
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9911141A external-priority patent/FR2797888A1/fr
Application filed by Bio Merieux, Inst Nat Sante Rech Med filed Critical Bio Merieux
Application granted granted Critical
Publication of ATE531726T1 publication Critical patent/ATE531726T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00960783T 1999-09-01 2000-09-01 Verfahren zum nachweis der expression eines hüllproteins eines endogenen menschlichen retrovirus und verwendungen des gens, das für solch ein protein kodiert ATE531726T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9911141A FR2797888A1 (fr) 1999-09-01 1999-09-01 Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine
FR9911793A FR2797889A1 (fr) 1999-09-01 1999-09-15 Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine
PCT/FR2000/002429 WO2001016171A1 (fr) 1999-09-01 2000-09-01 Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine

Publications (1)

Publication Number Publication Date
ATE531726T1 true ATE531726T1 (de) 2011-11-15

Family

ID=26235097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00960783T ATE531726T1 (de) 1999-09-01 2000-09-01 Verfahren zum nachweis der expression eines hüllproteins eines endogenen menschlichen retrovirus und verwendungen des gens, das für solch ein protein kodiert

Country Status (9)

Country Link
US (1) US7442550B1 (enExample)
EP (2) EP2385058B1 (enExample)
JP (2) JP4283475B2 (enExample)
AT (1) ATE531726T1 (enExample)
AU (1) AU7297100A (enExample)
CA (1) CA2383877C (enExample)
ES (2) ES2444649T3 (enExample)
FR (1) FR2797889A1 (enExample)
WO (1) WO2001016171A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004678A2 (en) * 2000-07-07 2002-01-17 Genetics Institute, Llc. Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders
WO2004087748A1 (en) 2003-04-04 2004-10-14 Centre National De La Recherche Scientifique Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same
FR2865403B1 (fr) * 2004-01-23 2009-06-12 Biomerieux Sa Composition pour le traitement d'une pathologie associee a la msrv/herv-w
ES2380228T3 (es) * 2005-03-30 2012-05-09 Viroxis Retrovirus endógeno y proteínas codificadas por env como diana para el tratamiento del cancer
KR101164602B1 (ko) 2008-01-09 2012-07-10 주식회사 케이알바이오텍 배큘로바이러스?기반 백신
EP3235828A1 (en) 2016-04-21 2017-10-25 Genethon Stable pseudotyped lentiviral particles and uses thereof
CN111225682A (zh) 2017-10-20 2020-06-02 吉尼松公司 合胞素用于将药物和基因靶向递送至肺组织的用途
WO2019077149A1 (en) 2017-10-20 2019-04-25 Genethon USE OF SYNCYTINE FOR TARGETING DRUG AND GENE ADMINISTRATION TO REGENERATE MUSCLE TISSUE
JP7344300B2 (ja) 2018-09-18 2023-09-13 ブイエヌブイ ニューコ インク． Ａｒｃベースのカプシドおよびその使用
US11129892B1 (en) 2020-05-18 2021-09-28 Vnv Newco Inc. Vaccine compositions comprising endogenous Gag polypeptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663040B1 (fr) 1990-06-11 1995-09-15 Bio Merieux Procede de detection d'une sequence nucleotidique selon la technique d'hybridation sandwich.
US6312921B1 (en) * 1996-07-26 2001-11-06 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CA2298834C (fr) * 1997-07-07 2015-03-10 Bio Merieux Sequences retroviraux endogenes, associees a des maladies auto-immunes et/ou a des perturbations de la grossesse
WO1999060020A1 (en) * 1998-05-18 1999-11-25 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them

Also Published As

Publication number Publication date
EP2385058A1 (fr) 2011-11-09
JP4283475B2 (ja) 2009-06-24
ES2376726T3 (es) 2012-03-16
JP4824731B2 (ja) 2011-11-30
AU7297100A (en) 2001-03-26
EP2385058B1 (fr) 2013-11-06
EP1212359A1 (fr) 2002-06-12
ES2444649T3 (es) 2014-02-26
JP2003510032A (ja) 2003-03-18
CA2383877A1 (fr) 2001-03-08
JP2009072194A (ja) 2009-04-09
EP1212359B1 (fr) 2011-11-02
CA2383877C (fr) 2014-04-15
FR2797889A1 (fr) 2001-03-02
US7442550B1 (en) 2008-10-28
WO2001016171A1 (fr) 2001-03-08

Similar Documents

Publication Publication Date Title
Taylor et al. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines
ATE531726T1 (de) Verfahren zum nachweis der expression eines hüllproteins eines endogenen menschlichen retrovirus und verwendungen des gens, das für solch ein protein kodiert
EP0701563A4 (en) GEN TRANSFER FOR TREATING CONSTRUCTIVE TISSUE OF A MAMMAL HOST
DE50015518D1 (de) vERFAHREN ZUR VERRINGERUNG DER ANTIGENITÄT DES ADENO-ASSOZIIERTEN VIRUS STRUKTURPROTEINS
Satyamoorthy et al. The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: pleiotropic effects of YY1 on distinct DNA promoter elements
IL149922A (en) Tweak receptor antagonist for use in regulating the angiogenesis process, a nucleic acid encoded by the antagonist, expression and host cells that contain the expression carrier and the antagonist to produce the antagonist
DK1783225T3 (da) Strukturprotein fra AAV, dets fremstilling og anvendelse
JP2007289186A (ja) Ｄｐ７５をコードするｄｎａおよびその使用のための工程
EP1005540A4 (en) IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS
DE69934688D1 (de) Durch mechanischen stress induzierte gene, deren expressionsprodukte und deren verwendung.
DE69434926D1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
DE69840333D1 (de) 2-m übergang des zellzyklus
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
WO2002040672A3 (en) Compositions and methods relating to breast specific genes and proteins
Naryshkin et al. Chemical cross-linking of the human immunodeficiency virus type 1 Tat protein to synthetic models of the RNA recognition sequence TAR containing site-specific trisubstituted pyrophosphate analogues
DE60044350D1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
ATE162721T1 (de) Neue sonde zur tumordiagnostik oder tumortherapie
WO2002040673A3 (en) Compositions and methods relating to lung specific genes and proteins
CN105132550B (zh) 检测muc21基因表达的试剂在制备骨关节炎诊治产品中的应用
Kanae et al. Expression of the PTEN tumor suppressor gene in malignant mammary gland tumors of dogs
Kim et al. Antisense oligodeoxynucleotide of glyceraldehyde-3-phosphate dehydrogenase gene inhibits cell proliferation and induces apoptosis in human cervical carcinoma cell lines
JP2003510032A5 (enExample)
Yamasaki et al. A case of intramuscular cysticercosis diagnosed definitively by mitochondrial DNA analysis of extremely calcified cysts
DE3750180D1 (de) Laminin bindende peptidfragmente.
WO2004053075A3 (en) Compositions, splice variants and methods relating to breast specific genes and proteins